• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Regulation

PE roll-up strategies face regulatory heat with focus on consumer industries

  • Wahida Ahmed
  • 12 April 2023
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Multiple sector acquisitions by private equity (PE) funds т€“ or т€˜roll-upт€™ strategies - are increasingly drawing the attention of competition authorities, with a spotlight on large portfolios in consumer-facing industries, lawyers told Unquote sister publication PaRR.

Amid a slowdown in PE platform deals due to the debt crunch, GPs have turned their attention to existing portfolio companies focusing on roll-up strategies, as reported. At the same time, top competition officials have been making statements about roll-up deals being an enforcement priority.

Roll-up strategies have been raising eyebrows at competition agencies, particularly in those industries dominated by funds that own controlling stakes in multiple companies, said Clemens York and Michael Okkonen, both partners at Dechert. With longer holding periods anticipated due to delayed sponsor exits amid the financing drought, some PE portfolios have become so large – with an increasing sector-specific focus – that they are attracting greater attention from the regulators, York said. As dealmaking picks up again, roll-ups will be scrutinised more carefully and more often in heavily consolidated industries, Okkonen said.

Recent examples come from the UK, where the head of the Competition and Markets Authority (CMA), Sarah Cardell, recently flagged roll-up deals as an enforcement priority, particularly where they impact consumers.

The CMA has conducted merger reviews of several roll-up deals in the past few years where remedies – in the form of divestments – have been required in order to secure approvals, noted Patrick Harrison, partner at Sidley Austin. The CMA has typically been focused on roll-ups involving goods and services, especially where local markets are involved, said Thomas McGrath, partner at Freshfields Bruckhaus Deringer. In cases involving local markets, for example dental care, there may be concentration in smaller catchment areas like individual towns, whilst market shares at a national level remain modest, he noted.

The CMA is currently reviewing Core Equity Holdings: Portman Healthcare / Dentex, in which the CMA found that the merger will substantially lessen competition in certain local areas within the NHS and private dental treatments.

Several CMA cases have led to Phase 1 divestments, typically those that provide goods and services to consumers, Harrison said, including CD&R/Morrisons (2022), CapVest Partners: Riviera Bidco / Dental Partners Group (2022); BDT Capital Partners LLC: Culligan / Waterlogic (2022); and TDR Capital LLP: Bellis Acquisition Company 3 / Asda Group (2021).

Veterinary services are among sectors that have received CMA scrutiny, as reported by PaRR. Last year CVS's acquisition of Quality Pet Care (also known as The Vet) was one example. CVS sold the business following the investigation. BC Partners-backed VetPartners' acquisition of Goddard Veterinary Group in March 2022 resulted in Phase 1 divestment remedies and the CMA noted that larger corporate groups buying smaller independent businesses resulted in anti-competitive situations. The CMA is also investigating whether seventeen completed acquisitions by CVC Capital Partners-backed Medivet Group of independent veterinary businesses could lessen competition.

Going forward, GPs will need to assess plans for serial acquisitions more strategically from the outset, McGrath said. "It is important to analyse the collective impact of serial acquisitions rather than only assess the risk profile of each individual deal on a standalone basis. Regulators are no longer thinking about every bolt-on independently, but the aggregate effect of them on the market as a whole," he said.

"The CMA can and does use its share of supply test extremely flexibly to review deals that may be of substantive interest", said McGrath. The UK agency is "very well-positioned to look at any and all deals," compared to other regulators, he said.

According to McGrath, similar cases will be brought by authorities in EU member states. Regulatory obstacles for PE firms are increasing overall, said York, who flagged that in addition to merger control, GPs also need to consider the Foreign Subsidies Regulation and Foreign direct investment (FDI) screening in the EU.

Camille Paulhac, partner at Paul Hastings, noted that clients increasingly seek M&A advice early in the deal process to determine if competition law will be an issue. The increased scrutiny from regulators may further delay PE exits, as bids that have an attractive offer but raise competition concerns that put closing in jeopardy, may be seen less favourably by the sellers than a lower bid with more certainty on closing, York said. Where a deal raises substantive issues, GPs often look for contractual protection to make sure that the deal does go through and that they are sufficiently compensated if one of the regulators does not see any viable remedy to its competition concerns, other than blocking the deal, he noted.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Regulation
  • Investments
  • UK / Ireland
  • Benelux
  • CEE
  • DACH
  • France
  • Nordics
  • Southern Europe
  • Consumer
  • Healthcare
  • Sidley Austin
  • Dechert
  • BC Partners
  • Freshfields Bruckhaus Deringer
  • Paul Hastings
  • CapVest Equity Partners
  • TDR Capital
  • CVC Capital Partners
  • Exclusive

More on Regulation

EU FSR could impact PE fundraising with potential rise in 'clean funds'
EU FSR could impact PE fundraising with potential rise in 'clean funds'

FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely

  • Regulation
  • 01 September 2023
CMA scrutiny of high-leverage PE divestment purchases expected to increase
CMA scrutiny of high-leverage PE divestment purchases expected to increase

PE could stand to lose its historic advantage with heightened regulatory baggage

  • Regulation
  • 21 August 2023
EU Foreign Subsidies rules hold specific challenges for PE
EU Foreign Subsidies rules hold specific challenges for PE

Sovereign wealth funds and pension funds commitments may trigger EC attention under new EU foreign subsidies regulation

  • Regulation
  • 22 June 2023
PE roll-up strategies face regulatory heat with focus on consumer industries
PE roll-up strategies face regulatory heat with focus on consumer industries

With longer holding periods facilitating more bolt-ons, regulators including the UK's CMA are intervening

  • Regulation
  • 12 April 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013